A Split Face Comparative Study Of Microneeding With Platelet Rich Plasma Versus Fractional Co2 Laser With Platelet Rich Plasma In Management Of Atrophic Acne Scars
DOI:
https://doi.org/10.48165/ijabms.2020.22203Keywords:
Acne Scars, Microneedling, Fractional CO2 Laser, PRPAbstract
Introduction: Acne scars, a disfiguring malady is a challenge for dermatologists, despite having multiple treatment modalities like subsicion, microneedling, dermabrasion, TCA CROSS, Fractional CO2 Laser, dermal fillers, etc. However, monotherapy has been hardly satisfactory because of the polymorphism seen with the scars. Platelet Rich Plasma (the autologous plasma with high concentration of platelets) has been versatile since its advent. It has been revolutionary in the management of acne scars by providing numerous growth factors aiding in scar remodelling along with time proven methods.
Materials & Methods: A prospective analytical study was conducted over a period of 6 months including 26 patients. Each patient received microneedling plus PRP on right side of the face while Fractional CO2 Laser plus PRP on the left side simultaneously for total 6 such sittings at 21 days interval. Response was noted with serial photographs and goodman’s qualitative and quantitative scores. Autologous PRP was prepared with double spin method to yield uniformly high amount of platelets.
Results: Out of 26 patients enrolled in the study, none of the patient reported a poor response which means both the modalities are effective. The Average Qualitative score, pre and post treatment showed significant difference with 10 patients showing excellent results in Fractional CO2 Laser treated side.
Conclusion: Fractional CO2 Laser is a non invasive procedure with PRP boosting the end results in acne scar treatment, hence should be considered one of the first line treatments.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Avanitaben D. Solanki, Kartavya Banker, Jigna Barot, Niraj Dhinoja
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.